Advancing In Vivo RNA Therapies Towards Clinical in B-Cell-Mediated Autoimmune Diseases

Time: 4:30 pm
day: Conference Day One P3

Details:

• Share data highlighting the benefits of in vivo therapies in autoimmune diseases
• Share NHP preclinical data highlighting the benefits of in vivo RNA therapy
• Highlight the development of in vivo CAR-T therapy for the clinic

Speakers:

Gilles Besin With over 15 years of experience in immunology and vaccine development, Gilles Besin is currently the Chief Scientific Officer at Orbital Therapeutics. Before joining Orbital, Read more